Belpointe Asset Management LLC Buys Shares of 32,161 Oscar Health, Inc. $OSCR

Key Points

• Belpointe Asset Management LLC has purchased 32,161 shares of Oscar Health, Inc., valued at approximately $690,000, according to their recent 13F filing.
• Oscar Health has seen a significant increase in institutional ownership, with 75.70% of the stock owned by institutional investors and hedge funds.
• Multiple analysts have downgraded their target prices for Oscar Health, now averaging around $12.64, with most ratings leaning towards a "Strong Sell."

Belpointe Asset Management LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 32,161 shares of the company's stock, valued at approximately $690,000.

Other institutional investors also recently bought and sold shares of the company. Victory Capital Management Inc. boosted its stake in Oscar Health by 23.8% in the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock valued at $3,749,000 after acquiring an additional 54,938 shares in the last quarter. Concurrent Investment Advisors LLC purchased a new position in shares of Oscar Health in the first quarter worth $677,000. Nuveen LLC purchased a new position in shares of Oscar Health in the first quarter worth $29,684,000. NewEdge Advisors LLC raised its holdings in shares of Oscar Health by 89.7% in the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company's stock worth $2,465,000 after buying an additional 88,946 shares during the last quarter. Finally, Matauro LLC purchased a new position in shares of Oscar Health in the second quarter worth $1,508,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider owned 501,148 shares in the company, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 24.39% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on OSCR shares. Wells Fargo & Company raised their target price on shares of Oscar Health from $10.00 to $14.00 and gave the stock an "underweight" rating in a report on Tuesday. Robert W. Baird reissued a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Raymond James Financial cut shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Weiss Ratings reissued a "sell (d)" rating on shares of Oscar Health in a report on Wednesday. Finally, Piper Sandler reduced their target price on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a report on Thursday, August 14th. Four analysts have rated the stock with a Hold rating and six have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Strong Sell" and an average price target of $12.64.

Oscar Health Stock Down 3.0%

OSCR stock opened at $21.79 on Thursday. The firm has a market cap of $5.63 billion, a PE ratio of -26.90 and a beta of 1.89. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The firm's fifty day moving average is $17.54 and its 200 day moving average is $15.77. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. The company had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm's revenue was up 29.0% on a year-over-year basis. During the same quarter last year, the business earned $0.20 earnings per share. On average, research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.